Marshview Life Science Advisors

Marshview Life Science Advisors is a specialized consultancy firm that provides strategic advisory services to biotechnology and pharmaceutical companies, focusing on drug development, regulatory science, and safety pharmacology. Founded by Dr. Thomas J. Colatsky, a former senior official at the U.S. Food and Drug Administration (FDA), the firm assists clients in navigating the complexities of the regulatory review process. Marshview is particularly recognized for its expertise in cardiac safety and its contributions to the Comprehensive in vitro Proarrhythmia Assay (CiPA) initiative. The company provides guidance on drug discovery design, target validation, and the application of in silico modeling in regulatory submissions.